IGCL Indogulf Cropsciences Q1 FY26 results (Apr–Jun 2025) and concall
Indogulf Cropsciences Limited reported a strong Q1 FY26, with revenue growing 43.3% YoY to INR 189.4 crores and PAT surging 187.4% to INR 3.9 crores. This growth was primarily driven by domestic B2B and B2C segments, alongside robust performance in biologicals and plant nutrition. Despite a slight gross margin compression due to product mix, management expressed confidence in margin recovery and continued growth, supported by strategic capex, new product launches, and an improving working capital cycle.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 233 | 98 | 123 | 185 |
| EBITDA | 27 | 10 | 20 | 9 |
| Net profit | 17 | 4 | 10 | 3 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
